151 related articles for article (PubMed ID: 36009589)
21. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
22. Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.
Clarke TL; White DA; Osborne ME; Shaw AM; Smart NJ; Daniels IR
Ann R Coll Surg Engl; 2017 May; 99(5):373-377. PubMed ID: 28462648
[TBL] [Abstract][Full Text] [Related]
23. Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy.
Sun W; Li G; Wan J; Zhu J; Shen W; Zhang Z
Oncotarget; 2016 Oct; 7(43):69507-69517. PubMed ID: 27486758
[TBL] [Abstract][Full Text] [Related]
24. A novel histologic grading scheme based on poorly differentiated clusters is applicable to treated rectal cancer and is associated with established histopathological prognosticators.
Yang M; Rehman AU; Zuo C; Sheehan CE; Lee EC; Lin J; Zhao Z; Choi E; Lee H
Cancer Med; 2016 Jul; 5(7):1510-8. PubMed ID: 27165693
[TBL] [Abstract][Full Text] [Related]
25. Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response.
McCoy MJ; Hemmings C; Anyaegbu CC; Austin SJ; Lee-Pullen TF; Miller TJ; Bulsara MK; Zeps N; Nowak AK; Lake RA; Platell CF
Oncotarget; 2017 Mar; 8(12):19803-19813. PubMed ID: 28177891
[TBL] [Abstract][Full Text] [Related]
26. Immunogenomic profiles associated with response to neoadjuvant chemoradiotherapy in patients with rectal cancer.
Akiyoshi T; Tanaka N; Kiyotani K; Gotoh O; Yamamoto N; Oba K; Fukunaga Y; Ueno M; Mori S
Br J Surg; 2019 Sep; 106(10):1381-1392. PubMed ID: 31197828
[TBL] [Abstract][Full Text] [Related]
27. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
28. The Effectiveness and Safety of Open Versus laparoscopic Surgery for Rectal Cancer after Preoperative Chemo-radiotherapy: A Meta-Analysis.
Zhang JJ; Guo BL; Zheng QX; Chen ZY
Comb Chem High Throughput Screen; 2019; 22(3):153-159. PubMed ID: 30987563
[TBL] [Abstract][Full Text] [Related]
29. Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma.
Chang HJ; Jung KH; Kim DY; Jeong SY; Choi HS; Kim YH; Sohn DK; Yoo BC; Lim SB; Kim DH; Ahn JB; Kim IJ; Kim JM; Yoon WH; Park JG
Hum Pathol; 2005 Apr; 36(4):364-71. PubMed ID: 15891997
[TBL] [Abstract][Full Text] [Related]
30. NF-κB/p65 expression before and after treatment in rectal cancer patients undergoing neoadjuvant (chemo)radiotherapy and surgery: prognostic marker for disease progression and survival.
Voboril R; Rychterova V; Voborilova J; Kubecova M; Fanta J; Dvorak J
Neoplasma; 2016; 63(3):462-70. PubMed ID: 26952512
[TBL] [Abstract][Full Text] [Related]
31. Effect of Akt activation and experimental pharmacological inhibition on responses to neoadjuvant chemoradiotherapy in rectal cancer.
Koyama FC; Lopes Ramos CM; Ledesma F; Alves VAF; Fernandes JM; Vailati BB; São Julião GP; Habr-Gama A; Gama-Rodrigues J; Perez RO; Camargo AA
Br J Surg; 2018 Jan; 105(2):e192-e203. PubMed ID: 29341150
[TBL] [Abstract][Full Text] [Related]
32. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer.
Hoendervangers S; Couwenberg AM; Intven MPW; van Grevenstein WMU; Verkooijen HM
Eur J Surg Oncol; 2018 Jul; 44(7):1013-1017. PubMed ID: 29650419
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Significance of Neoadjuvant Rectal Score and Indication for Postoperative Adjuvant Therapy in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy.
Maeda K; Shibutani M; Tachimori A; Nishii T; Aomatsu N; Fukuoka T; Nagahara H; Otani H; Inoue T; Ohira M
In Vivo; 2020; 34(1):283-289. PubMed ID: 31882490
[TBL] [Abstract][Full Text] [Related]
34. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
McCoy MJ; Hemmings C; Hillery S; Penter C; Bulsara MK; Zeps N; Platell CF
ANZ J Surg; 2017 Dec; 87(12):E233-E239. PubMed ID: 26631340
[TBL] [Abstract][Full Text] [Related]
36. Defining response to radiotherapy in rectal cancer using magnetic resonance imaging and histopathological scales.
Siddiqui MR; Bhoday J; Battersby NJ; Chand M; West NP; Abulafi AM; Tekkis PP; Brown G
World J Gastroenterol; 2016 Oct; 22(37):8414-8434. PubMed ID: 27729748
[TBL] [Abstract][Full Text] [Related]
37. A longitudinal cohort study of watch and wait in complete clinical responders after chemo-radiotherapy for localised rectal cancer: study protocol.
Vatandoust S; Wattchow D; Sposato L; Michael MZ; Leung J; Gormly K; Chen G; Symonds EL; Tie J; Papanicolas LE; Woods S; Gebski V; Mead K; Kuruni A; Karapetis CS
BMC Cancer; 2022 Mar; 22(1):222. PubMed ID: 35232427
[TBL] [Abstract][Full Text] [Related]
38. MiRNA Expression Analysis of Pretreatment Biopsies Predicts the Pathological Response of Esophageal Squamous Cell Carcinomas to Neoadjuvant Chemoradiotherapy.
Wen J; Luo K; Liu H; Liu S; Lin G; Hu Y; Zhang X; Wang G; Chen Y; Chen Z; Li Y; Lin T; Xie X; Liu M; Wang H; Yang H; Fu J
Ann Surg; 2016 May; 263(5):942-8. PubMed ID: 26445467
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant chemo-radiotherapy and rectal cancer: can the UK watch and wait with Brazil?
Nyasavajjala SM; Shaw AG; Khan AQ; Brown SR; Lund JN
Colorectal Dis; 2010 Jan; 12(1):33-6. PubMed ID: 19832875
[TBL] [Abstract][Full Text] [Related]
40. Tumor microRNAs Identified by Small RNA Sequencing as Potential Response Predictors in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
Machackova T; Trachtova K; Prochazka V; Grolich T; Farkasova M; Fiala L; Sefr R; Kiss I; Skrovina M; Dosoudil M; Berindan-Neagoe I; Svoboda M; Slaby O; Kala Z
Cancer Genomics Proteomics; 2020; 17(3):249-257. PubMed ID: 32345666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
